Smith & Nephew (LON:SN) Rating Reiterated by Berenberg Bank

Smith & Nephew (LON:SN)‘s stock had its “buy” rating reiterated by equities researchers at Berenberg Bank in a note issued to investors on Thursday, MarketBeat.com reports. They currently have a GBX 1,450 ($18.21) target price on the stock. Berenberg Bank’s price objective indicates a potential upside of 45.47% from the stock’s current price.

Several other brokerages have also weighed in on SN. JPMorgan Chase & Co. reaffirmed an “overweight” rating and set a GBX 1,300 ($16.33) target price on shares of Smith & Nephew in a research note on Thursday, April 18th. Royal Bank of Canada reaffirmed an “outperform” rating and set a GBX 1,500 ($18.84) price objective on shares of Smith & Nephew in a research report on Friday, April 5th. Finally, Barclays reissued an “equal weight” rating and issued a GBX 1,150 ($14.45) target price on shares of Smith & Nephew in a research report on Friday, February 9th. One investment analyst has rated the stock with a hold rating and five have assigned a buy rating to the company’s stock. According to data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and an average target price of GBX 1,346.20 ($16.91).

Smith & Nephew Price Performance

Shares of SN stock opened at GBX 996.80 ($12.52) on Thursday. The company has a debt-to-equity ratio of 59.11, a current ratio of 1.77 and a quick ratio of 0.84. The company has a market capitalization of £8.72 billion, a PE ratio of 4,106.67, a price-to-earnings-growth ratio of 0.46 and a beta of 0.51. The firm’s 50-day moving average is GBX 1,021.40 and its two-hundred day moving average is GBX 1,034.26. Smith & Nephew has a 12 month low of GBX 887 ($11.14) and a 12 month high of GBX 1,316.75 ($16.54).

About Smith & Nephew

Smith & Nephew plc, together with its subsidiaries, develops, manufactures, markets, and sells medical devices and services in the United Kingdom and internationally. It operates through three segments: Orthopaedics, Sports Medicine & ENT, and Advanced Wound Management. The company offers knee implant products for knee replacement procedures; hip implants for revision procedures; trauma and extremities products that include internal and external devices used in the stabilization of severe fractures and deformity correction procedures; and other reconstruction products.